{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:42:13Z","timestamp":1793472133699,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002216","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T00:00:00Z","timestamp":1176854400000}}],"reference-count":9,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002216.pub2","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T19:23:19Z","timestamp":1170789799000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic monitoring of antiepileptic drugs for epilepsy"],"prefix":"10.1002","volume":"2010","author":[{"given":"Torbj\u00f6rn","family":"Tomson","sequence":"first","affiliation":[{"name":"Karolinska University Hospital; Department of Neurology; Stockholm Sweden S-171 76"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Liisa","family":"Dahl","sequence":"additional","affiliation":[{"name":"Akademiska sjukhuset; Department of Clinical Pharmacology; 75185 Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Kimland","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital - Solna; Adverse Drug Monitoring Centre, Clinical Pharmacology L7:05; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,18]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD002216.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1528-1157.2000.tb00144.x","article-title":"A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy","volume":"41","author":"Jannuzzi","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD002216.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00313281","article-title":"A prospective randomised trial on the effect of monitoring plasma anticonvulsant levels in epilepsy","volume":"224","author":"Fr\u00f6scher","year":"1981","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD002216.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1528-1157.1959.tb04274.x","article-title":"Aspects of pharmacology of phenytoin (Dilantin) and phenobarbital relevant to their dosage in the treatment of epilepsy","volume":"1","author":"Buchtal","year":"1960","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD002216.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.294.6574.723","article-title":"Overuse of monitoring of blood concentrations of antiepileptic drugs","volume":"294","author":"Chadwick","year":"1987","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002216.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.1968.03140110061012","article-title":"Management of epilepsy with diphenylhydantoin sodium","volume":"203","author":"Kutt","year":"1968","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002216.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archneur.1974.00490410031001","article-title":"Usefulness of blood levels of antiepileptic drugs","volume":"31","author":"Kutt","year":"1974","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD002216.pub2-BIB0007|cit7","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD002216.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archneur.1974.00490410037002","article-title":"Anticonvulsant effect of diphenylhydantoin relative to plasma levels","volume":"31","author":"Lund","year":"1974","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD002216.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s002280050001","article-title":"Therapeutic monitoring of the new antiepileptic drugs","volume":"55","author":"Tomson","year":"2000","journal-title":"European Journal of Clinical Pharmacology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002216.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T09:47:01Z","timestamp":1649238421000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002216.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,4,18]]},"references-count":9,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002216.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,18]]}}}